研究目的: To evaluate the maximum tolerated dose (MTD) of choline salicylate (CS) that can be combined with selinexor twice weekly in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL) or mantle cell lymphoma (MCL). (Primary)

项目负责人:  Jonas Paludo, M.D., Mayo Clinic in Rochester, Minnesota, United States

联系方式: Clinical Trials Referral Office   Phone: +1-855-776-0015   Email: mayocliniccancerstudies@mayo.edu  

要求患者参与: 18 Years and older 

ClinicalTrials.gov 标识符: NCT04640779